News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
WEBER ECKARD
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/07/2019 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Alliqua BioMedical, Inc.
Txns:
| Granted 85,254 shares
@ $0 Granted 396 options to buy
@ $1.39, valued at
$550.4 Granted 55,879 options to buy
@ $3.06, valued at
$171k
|
|
05/07/2019 |
3
| WEBER ECKARD (Director) has filed a Form 3 on Alliqua BioMedical, Inc. |
12/11/2017 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Disposed/sold 344,719 shares
@ $1.52, valued at
$524k
Disposed/sold 11,969 shares
@ $1.52, valued at
$18.2k
Disposed/sold 12,500 shares
@ $1.52, valued at
$19k
Disposed/sold 2,992 options to buy
@ $1.84, valued at
$5.5k
Disposed/sold 20,000 options to buy
@ $7.85, valued at
$157k
Disposed/sold 10,000 options to buy
@ $7.84, valued at
$78.4k
Disposed/sold 10,000 options to buy
@ $3.76, valued at
$37.6k
Disposed/sold 12,500 options to buy
@ $2.26, valued at
$28.3k
|
|
06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/03/2016 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc. |
06/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/14/2016 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 17,778 options to buy
@ $7.91, valued at
$140.6k
|
|
01/06/2016 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Gifted 11,969 shares
@ $0 Exercised 11,969 options to buy
@ $0.92, valued at
$11k
|
|
07/13/2015 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 15,500 options to buy
@ $16.52, valued at
$256.1k
|
|
06/22/2015 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $3.76, valued at
$37.6k
|
|
06/10/2015 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $4.63, valued at
$231.5k
|
|
05/07/2015 |
4/A
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 243,726 shares
@ $0 Granted 4,332 options to buy
@ $0 |
|
05/07/2015 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Tobira Therapeutics, Inc.
Txns:
| Granted 243,726 shares
@ $0 Granted 36,187 shares
@ $0 Granted 3,553,322 shares
@ $0 Granted 47,613 shares
@ $0 Granted 4,332 options to buy
@ $0 |
|
01/21/2015 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Atara Biotherapeutics, Inc.
Txns:
| Granted 25,000 options to buy
@ $25.15, valued at
$628.8k
|
|
06/27/2014 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Orexigen Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $5.97, valued at
$298.5k
|
|
06/20/2014 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $7.84, valued at
$78.4k
|
|
12/23/2013 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Granted 20,000 options to buy
@ $7.85, valued at
$157k
|
|
07/16/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/16/2013 |
3
| WEBER ECKARD (Director) has filed a Form 3 on Ocera Therapeutics, Inc. |
06/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/11/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/06/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/28/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/29/2009 |
4
| WEBER ECKARD (Director) has filed a Form 4 on Orexigen Therapeutics, Inc. |
|
|